Scholar Rock Holding Corp (SRRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRRK | AXSM | APLS | ||
| Company | Scholar Rock Holding Corp | Axsome Thera | Apellis Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 41.76 | 88.82 | 33.16 | ||
| High | 45.84 | 93.12 | 34.27 | ||
| Low | 41.53 | 87.69 | 32.89 | ||
| Last | 44.78 | 90.73 | 33.21 | ||
| Change | +2.69 | +0.99 | +0.07 | ||
| % Change | +6.39% | +1.10% | +0.21% | ||
| Volume | 2,884,100 | 956,300 | 3,733,200 | ||
| 20-Day Average Volume | 1,345,110 | 499,610 | 3,212,990 | ||
| Previous Close | 42.09 | 89.74 | 33.14 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.79 | 96.19 | 33.63 | ||
| 20-Day Raw Stochastic | 92.90% | 20.64% | 68.66% | ||
| 20-Day Relative Strength | 67.33% | 45.02% | 54.11% | ||
| Weighted Alpha | -9.43 | +17.86 | -40.95 | ||
| Today's Opinion | 100% Buy | 40% Buy | 24% Sell | ||
| Previous Opinion | 100% Buy | 40% Buy | 24% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.67% since 12/13/24 | +0.70% since 12/13/24 | +0.06% since 12/13/24 | ||
| Low | 40.22 on 12/19/24 | 87.69 on 12/20/24 | 32.71 on 12/16/24 | ||
| High | 45.84 on 12/20/24 | 94.64 on 12/18/24 | 35.71 on 12/18/24 | ||
| 1-Month | |||||
| %Chg | +60.73% since 11/20/24 | -4.09% since 11/20/24 | +20.81% since 11/20/24 | ||
| Low | 25.88 on 11/21/24 | 87.69 on 12/20/24 | 26.62 on 11/21/24 | ||
| High | 46.19 on 12/10/24 | 102.42 on 12/04/24 | 35.72 on 12/09/24 | ||
| 3-Month | |||||
| %Chg | +376.89% since 09/20/24 | -5.33% since 09/20/24 | +2.15% since 09/20/24 | ||
| Low | 6.76 on 10/03/24 | 80.85 on 10/10/24 | 24.34 on 11/05/24 | ||
| High | 46.19 on 12/10/24 | 105.00 on 11/13/24 | 35.72 on 12/09/24 | ||
| 6-Month | |||||
| %Chg | +439.52% since 06/20/24 | +20.68% since 06/20/24 | -16.41% since 06/20/24 | ||
| Low | 6.76 on 10/03/24 | 72.21 on 08/05/24 | 24.34 on 11/05/24 | ||
| High | 46.19 on 12/10/24 | 105.00 on 11/13/24 | 42.47 on 07/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,192,079 | 4,396,958 | 4,131,091 | ||
| Shares Outstanding, K | 93,615 | 48,462 | 124,393 | ||
| Annual Sales | 0 | 270,600,000 | 396,590,000 | ||
| Annual Net Income | -165,790,000 | -239,240,000 | -528,630,000 | ||
| Last Quarter Sales | 0 | 104,760,000 | 196,830,000 | ||
| Last Quarter Net Income | -64,480,000 | -64,600,000 | -57,450,000 | ||
| 60-Month Beta | 0.58 | 1.18 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.66 on 11/12/24 | -1.34 on 11/12/24 | -0.46 on 11/05/24 | ||
| Latest Earnings Date | 11/12/24 | 11/12/24 | 11/05/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||